National Drug Strategy
National Drug Strategy

Comorbidity of mental disorders and substance use: a brief guide for the primary care clinician

7.8 Major clinical issues with psychosis and inhalent/ solvent use

prev pageTOC |next page

Table of contents

7.8.1 Effects of inhalants/ solvents on psychotic disorders

7.8.2 Interactions between inhalants/ solvents and therapeutic agents for psychotic disorders

7.8.3 Management approaches to comorbid psychotic disorders and inhalant/ solvent use

prev pageTOC |next page